Get startedLog in
    Picture of Notable Labs logo

    NTBLQ — Notable Labs News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro Cap
    All News

    Brief: VBL Therapeutics Announces Appointment Of Sam Backenroth As CFO And Establishes Operations In The United States

    Picture of Notable Labs logoNotable Labs
    05/10/2021 13:13
    Oct 5 (Reuters) - Vascular Biogenics Ltd  VBLT.O :
    * VBL THERAPEUTICS ANNOUNCES APPOINTMENT OF SAM BACKENROTH
AS
CHIEF FINANCIAL OFFICER AND ESTABLISHES OPERATIONS IN THE UNITED
STATES
    * VBL THERAPEUTICS ANNOUNCES APPOINTMENT OF SAM BACKENROTH
AS
CHIEF FINANCIAL OFFICER AND ESTABLISHES OPERATIONS IN THE UNITED
STATES
    * VBL THERAPEUTICS - MOST RECENTLY, BACKENROTH WAS CHIEF
FINANCIAL
OFFICER AT NEUBASE THERAPEUTICS

Source text for Eikon:  ID:nGNX7djJtq 
Further company coverage:  VBLT.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Notable Labs

    See all news